Altar Rock’s AbbVie ABBV Stock Holding History

Altar Rock’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$215K	Sell	854 -392	-31%	-$84.3K	0.31%	60
2026 Q1	$271K	Buy	1,246 +1	+0.1%	+$222	0.32%	68
2025 Q4	$284K	Buy	+1,245	New	+$284K	0.34%	57

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Altar Rock's ABBV Position: Q2 2026 in Review

Altar Rock reduced its AbbVie (ABBV) stake by 31% in Q2 2026, selling an estimated $84.3K and leaving 854 shares worth $215K. The position accounts for 0.31% of the portfolio, ranked #60.

Altar Rock first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. The position peaked at $284K in Q4 2025. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Altar Rock held 854 shares of AbbVie worth $215K as of Q2 2026.
Altar Rock sold 392 AbbVie shares in Q2 2026, an estimated $84.3K.
AbbVie made up 0.31% of Altar Rock's portfolio in Q2 2026, its #60 holding.
Altar Rock first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
Altar Rock's AbbVie position peaked at $284K in Q4 2025.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Altar Rock's 13F filing for Q2 2026, filed 21 Sep 2026.